Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CNY 250.53 million compared to CNY 205.58 million a year ago. Net income was CNY 15.54 million compared to CNY 5.56 million a year ago. Basic earnings per share from continuing operations was CNY 0.0093 compared to CNY 0.0033 a year ago. Diluted earnings per share from continuing operations was CNY 0.0093 compared to CNY 0.0033 a year ago.
For the nine months, sales was CNY 689.4 million compared to CNY 596.78 million a year ago. Net income was CNY 35.89 million compared to CNY 25.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.0214 compared to CNY 0.015 a year ago. Diluted earnings per share from continuing operations was CNY 0.0214 compared to CNY 0.015 a year ago.